You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-infectious intermediate, posterior and panuveitis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Uveitis, Posterior, Uveitis, Anterior, Uveitis, Intermediate Trial in Waltham (Ixekizumab Prefilled Syringe)

Recruiting
  • Uveitis, Posterior
  • +3 more
  • Ixekizumab Prefilled Syringe
  • Waltham, Massachusetts
    Massachusetts Eye Research and Surgery Institution
Oct 11, 2023

Non-infectious Uveitis Trial (care strategy)

Not yet recruiting
  • Non-infectious Uveitis
  • care strategy
  • (no location specified)
Jun 26, 2023

Uveitis Posterior Non-Infectious, Uveitis, Intermediate, Noninfectious Panuveitis Trial in Waltham, Erie (ESK-001)

Recruiting
  • Uveitis Posterior Non-Infectious
  • +2 more
  • Waltham, Massachusetts
  • +1 more
Jul 18, 2023

Uveitis, Posterior, Uveitis, Intermediate, Panuveitis Trial (Ozurdex 0.7mg Ophthalmic Implant, Prednisone)

Recruiting
  • Uveitis, Posterior
  • +2 more
  • Ottawa, Ontario, Canada
    Ottawa Hospital Research Institute - Vision Research Centre
Dec 14, 2022

Non-infectious Uveitis Trial in France, United Kingdom (pEYS606)

Completed
  • Non-infectious Uveitis
  • pEYS606
  • Grenoble, France
  • +3 more
Mar 9, 2022

Non-infectious Intermediate Posterior- or Pan-uveitis Trial in China (Adalimumab)

Recruiting
  • Non-infectious Intermediate Posterior- or Pan-uveitis
  • Beijing, Beijing, China
  • +7 more
Dec 6, 2022

Uveitis Trial in United States (Izokibep, Placebo)

Recruiting
  • Uveitis
  • Phoenix, Arizona
  • +20 more
Jan 11, 2023

Uveitis Trial (adalimumab)

Completed
Has Results
  • Uveitis
  • (no location specified)
Jul 8, 2021

Adalimumab for Non-infectious Intermediate, Posterior, or

Completed
  • Non-infectious Intermediate, Posterior and Panuveitis
    • Busan, Busan Gwang Yeogsi, Korea, Republic of
    • +16 more
    Jul 13, 2021

    Uveitis Trial (Adalimumab, Prednisone, Placebo)

    Completed
    Has Results
    • Uveitis
    • (no location specified)
    Jul 2, 2021

    Non-infectious Intermediate Uveitis, Non-infectious Posterior Uveitis, Non-infectious Panuveitis Trial in United Kingdom, United

    Completed
    Has Results
    • Non-infectious Intermediate Uveitis
    • +2 more
    • Golden, Colorado
    • +7 more
    Dec 9, 2020

    Uveitis, Intermediate Uveitis, Posterior Uveitis Trial in Palo Alto (Intravitreal injection 440mcg, Intravitreal injection of

    Recruiting
    • Uveitis
    • +3 more
    • Intravitreal injection 440mcg
    • Intravitreal injection of sirolimus 880mcg
    • Palo Alto, California
      Stanford University
    May 5, 2021

    Uveitis, Uveitis, Posterior, Uveitis, Anterior Trial in United States (4 mg CLS-TA Suprachoriodal Injection)

    Completed
    Has Results
    • Uveitis
    • +4 more
    • 4 mg CLS-TA Suprachoriodal Injection
    • Phoenix, Arizona
    • +9 more
    Jun 18, 2021

    Uveitis, Intermediate Uveitis, Posterior Uveitis Trial in Chicago, Omaha, Cleveland (triamcinolone acetonide (Triesence®))

    Completed
    Has Results
    • Uveitis
    • +4 more
    • triamcinolone acetonide (Triesence®)
    • Chicago, Illinois
    • +2 more
    Feb 17, 2021

    Uveitis Trial (Adalimumab, Prednisone, Placebo)

    Completed
    Has Results
    • Uveitis
    • Adalimumab
    • +2 more
    • (no location specified)
    Jul 2, 2021

    Non-infectious Uveitis Who Participated in CLS1001-301

    Completed
    Has Results
    • Uveitis
    • +4 more
    • 4 mg CLS-TA Suprachoriodal Injection
    • Sham procedure
    • Phoenix, Arizona
    • +15 more
    May 13, 2021

    Uveitis, Macular Edema, Uveitis, Posterior Trial in United States (4 mg CLS-TA, 0.8 mg CLS-TA)

    Completed
    Has Results
    • Uveitis
    • +5 more
    • 4 mg CLS-TA
    • 0.8 mg CLS-TA
    • Miami, Florida
    • +10 more
    Jan 18, 2021

    Uveitis, Uveitis, Posterior, Uveitis, Anterior Trial in Plano (Yutiq 0.18 MG Drug Implant, Sham Injection)

    Not yet recruiting
    • Uveitis
    • +3 more
    • Yutiq 0.18 MG Drug Implant
    • Sham Injection
    • Plano, Texas
      Texas Retina Associates
    Aug 3, 2022

    Humira® Therapy on Ocular Inflammation, Selected Health Care

    Completed
    • Uveitis
      • Graz, Steiermark, Austria
      • +27 more
      Feb 9, 2021

      Uveitis, Uveitis, Posterior, Uveitis, Intermediate Trial in Waltham (Sham Injector, FAI Insert)

      Active, not recruiting
      • Uveitis
      • +2 more
      • Sham Injector
      • FAI Insert
      • Waltham, Massachusetts
        EyePoint Study Site
      Dec 20, 2022

      Uveitis Trial in United States (Izokibep, Prednisone/Prednisolone)

      Active, not recruiting
      • Uveitis
      • Los Angeles, California
      • +3 more
      Jul 18, 2022

      Uveitis, Posterior Uveitis, Panuveitis Trial in United States (AEB071)

      Completed
      • Uveitis
      • +2 more
      • Los Angeles, California
      • +12 more
      Dec 15, 2020

      Posterior Uveitis, Intermediate Uveitis, Panuveitis Trial in India (Sham Injection, FAI Insert)

      Completed
      Has Results
      • Posterior Uveitis
      • +2 more
      • Sham Injection
      • FAI Insert
      • Hyderabad, Andhra Pradesh, India
      • +14 more
      Jul 10, 2020

      Uveitis Trial in Guangzhou (Adalimumab plus Methotrexate)

      Recruiting
      • Uveitis
      • Adalimumab plus Methotrexate
      • Guangzhou, Guangdong, China
        Zhongshan Ophthalmic Center, Sun Yat-sen University
      Dec 26, 2021

      Uveitis Trial in Worldwide (AIN457, Placebo)

      Withdrawn
      • Uveitis
      • AIN457
      • Placebo
      • Arlington, Texas
      • +10 more
      Sep 24, 2020